関連する実験動画
Updated: Jan 13, 2026

06:19
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
1.3K
2025年以降の急性重症潰瘍性大腸炎の管理
Manjeet Kumar Goyal1, Syed Adeel Hassan2, Jeffrey Aaron Berinstein3
1Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Current gastroenterology reports
|January 7, 2026
まとめ
急性重症潰瘍性大腸炎(ASUC)の管理は進化しています。ヤヌスキナーゼ阻害剤のような新しいバイオマーカーと治療法は、結腸切除率を削減するのに有望ですが、個別化された治療には厳密な試験が必要です。
科学分野:
- 消化器病学
- 内科学
- 臨床治療学
背景:
- 急性重症潰瘍性大腸炎(ASUC)は、予後が最適でない重大な臨床的課題をもたらします。
- 進歩にもかかわらず、結腸切除率は依然として高く、治療戦略の改善が必要であることを示しています。
研究 の 目的:
- ASUCの医療戦略を最適化するための最近のエビデンスをレビューすること。
- 結腸切除率の削減と患者転帰の向上に焦点を当てる。
主な方法:
- 最近の科学文献および臨床研究の統合。
- 新規バイオマーカー、予測モデル、および新興治療薬の分析。
主要な成果:
- 新規バイオマーカーと予測モデルは、ASUC患者の結腸切除リスク層別化に役立ちます。
- インフリキシマブの強化投与は効果が一定であり、ヤヌスキナーゼ阻害剤は可能性を秘めていますが、さらなるエビデンスが必要です。
- 結腸切除は依然として重要な介入であり、現在の治療効果の限界を強調しています。
結論:
- 現代のASUC管理は、迅速なリスク層別化と個別化された先進治療を重視しています。
- 今後の研究では、新興薬剤の厳密な試験と個別化された予後ツールの開発に焦点を当てるべきです。
関連する概念動画
Inflammatory Bowel Disease V: Surgical Management
438
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
438
Drugs for Treatment of Ulcerative Colitis in IBD
449
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
449
Inflammatory Bowel Disease IV: Pharmacological Management
471
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
471
Peptic Ulcer Disease IV: Management
427
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
427
Inflammatory Bowel Disease I: Ulcerative Colitis
882
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
882
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
631
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
631

